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Abstract
Zinc finger nucleases (ZFN) are powerful tools for editing genes in cells. Here we use ZFNs to interrogate the biological
function of ADPGK, which encodes an ADP-dependent glucokinase (ADPGK), in human tumour cell lines. The hypothesis we
tested is that ADPGK utilises ADP to phosphorylate glucose under conditions where ATP becomes limiting, such as hypoxia.
We characterised two ZFN knockout clones in each of two lines (H460 and HCT116). All four clones had frameshift mutations
in all alleles at the target site in exon 1 of ADPGK, and were ADPGK-null by immunoblotting. ADPGK knockout had little or no
effect on cell proliferation, but compromised the ability of H460 cells to survive siRNA silencing of hexokinase-2 under oxic
conditions, with clonogenic survival falling from 2163% for the parental line to 6.460.8% (p = 0.002) and 4.360.8%
(p= 0.001) for the two knockouts. A similar increased sensitivity to clonogenic cell killing was observed under anoxia. No
such changes were found when ADPGK was knocked out in HCT116 cells, for which the parental line was less sensitive than
H460 to anoxia and to hexokinase-2 silencing. While knockout of ADPGK in HCT116 cells caused few changes in global gene
expression, knockout of ADPGK in H460 cells caused notable up-regulation of mRNAs encoding cell adhesion proteins.
Surprisingly, we could discern no consistent effect on glycolysis as measured by glucose consumption or lactate formation
under anoxia, or extracellular acidification rate (Seahorse XF analyser) under oxic conditions in a variety of media. However,
oxygen consumption rates were generally lower in the ADPGK knockouts, in some cases markedly so. Collectively, the
results demonstrate that ADPGK can contribute to tumour cell survival under conditions of high glycolytic dependence, but
the phenotype resulting from knockout of ADPGK is cell line dependent and appears to be unrelated to priming of glycolysis
in these lines.
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Introduction
The identification of large numbers of candidate genes through
genomic analysis has created a pressing need for new approaches
for ascribing biological function. Highly sequence-specific zinc-
finger nucleases (ZFN) have utility for targeted gene editing in live
cells [1–6] and are one of the emerging functional genomics tools
for exploring genotype/phenotype relationships. Specifically,
dimeric ZFNs capable of recognising 18–42 base pair sequences
can be used to introduce double strand DNA breaks at unique
locations in the genome. These DNA breaks initiate error-prone
non-homologous end joining repair to generate site-specific,
heterogeneous mutations (predominantly small indels that disrupt
gene function) or, in the presence of a donor DNA sequence, to
introduce defined mutations via homology-directed repair. Recent
studies confirm the high sequence specificity of custom-designed
ZFNs in cells [7–10].
Here we utilise ZFN technology to interrogate the biological
function of a human gene, ADPGK, which encodes an ADP-
dependent glucokinase (ADPGK). Surprisingly, given extensive
investigation of glucose phosphorylation as the central reaction of
intermediary metabolism for many decades [11], mammalian
ADPGK was discovered only recently through its sequence
similarly to archaeal ADP-dependent glucokinases [12]. Phyloge-
netic analysis suggests the ancestral gene was laterally transferred
from Archaea early in metazoan evolution [12]. The purified
recombinant murine [12] and human [13] enzymes have been
confirmed to phosphorylate glucose, with the unusual feature (as
for the archaeal enyzmes [14]) that the phosphoryl donor is ADP
in contrast to the well-studied ATP-dependent vertebrate hexoki-
nase isoforms (HK1-4). Murine ADPGK is quite specific for
glucose, with lesser ability to phosphorylate mannose and fructose
(20% and 10% respectively of the rate with glucose); it has a low
apparent KM for both glucose (96 mM) and ADP (260 mM), and is
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inhibited by high concentrations of glucose and by its product
AMP but, unlike HK1-4, not by glucose-6-phosphate. The
biological role of eukaryotic ADPGKs is not well understood;
RNAi screens in C. elegans and HeLa cells have not identified a
phenotype [15–17], although a recent report has demonstrated a
role of ADPGK in T-cell receptor signalling through diversion of
glycolytic flux to the glycerol-3-phosphate dehydrogenase shuttle,
resulting in stimulation of mitochondrial production of reactive
oxygen species (ROS) [18]. However, the biochemical properties
of ADPGK, particularly its ability to utilise ADP, led us to
hypothesise that it may play a role in priming glycolysis under
stress conditions where ATP becomes limiting [12], such as under
hypoxia when cells become highly dependent on glycolytic ATP
generation [19].
Given the importance of glucose phosphorylation in tumour
metabolism, we focus here on the role of ADPGK in human
tumour cell lines. Tumour cells are highly dependent on glycolysis,
as first observed by Otto Warburg during the 1920s [20,21], and
the associated metabolic reprogramming has recently been
suggested as a possible hallmark of cancer [22]. In particular,
elevated glycolytic flux in tumour cells is considered to provide
intermediates for anabolic pathways and to increase antioxidant
defenses through NADPH generation via the pentose phosphate
pathway [23,24]. Expression of hexokinases is often up-regulated
in cancer cells as part of this metabolic switch [25]. ADPGK is
highly expressed in human tumours and tumour cell lines, at both
the mRNA and protein levels, although there is little indication of
up-regulation relative to normal tissues and (unlike many glycolytic
enzymes) it is not up-regulated by anoxia, hypoxia or HIF-1 in
tumour cell cultures and shows little dependence on extracellular
glucose concentration [13]. However, given that an emergency
response to ATP depletion would be mounted most rapidly by a
constitutively expressed enzyme, the lack of regulation of ADPGK
expression by hypoxia does not preclude a role in priming
glycolysis under these conditions.
Our initial attempt to test this hypothesis examined the effect of
suppressing ADPGK expression, with and without suppression of
HK2, in HCT116 and H460 human tumour cell lines using RNA
interference [13]. This study showed higher mRNA and protein
expression of both ADPGK and HK2 in H460 than in HCT116
cells, but did not demonstrate any significant effect on anaerobic
glycolysis (glucose consumption and lactate formation), or on
clonogenic cell survival under short term anoxia in either line,
although a small decrease in aerobic plating efficiency of H460
cells was shown when ADPGK was knocked down [13]. However,
inhibition of ADPGK expression was incomplete in this study
(typically ,60–90% reduction in protein indicated by western
blotting), raising the question as to whether residual ADPGK
activity may have masked the phenotype.
In the present study we circumvent the incomplete silencing of
ADPGK by using specific ZFNs to effect multi-allelic mutational
inactivation of the gene, generating ADPGK-null H460 and
HCT116 cell lines. The pair of ZFNs used here target a
genomically unique 37 base pair recognition sequence within the
first exon of the ADPGK gene. Two independent ADPGK-null
clones with confirmed frameshift mutations were generated in
each genetic background. These clones were characterised with
respect to proliferation, clonogenic survival and glycolytic flux
under aerobic and anaerobic conditions. Extracellular acidifica-
tion (as a measure of glycolysis) and mitochondrial oxygen
consumption were also measured using a Seahorse XF analyser.
Finally, the ability of these cell lines to grow as tumour xenografts,
and the steady state proportion of hypoxic cells in the resulting
tumours, were compared with parental lines.
Results
Generation of ADPGK-null Cell Lines using ZFNs
ADPGK was knocked out in two genetic backgrounds (HCT116
and H460) using CompoZrTM ZFNs custom-designed to introduce
double-strand breaks at a genomically unique target site in the first
exon of the ADPGK gene (Figure 1A). The ability of the ZFNs to
introduce mutations at this site was tested in HCT116 cells using
the SurveyorTM mutation detection assay (Figure 1B), following
lipid-based co-transfection with a GFP plasmid and FACS sorting
24 h later to enrich for transfected cells. A 473 bp region
surrounding the ZFN cut site was amplified by PCR and the
products were denatured and re-annealed to generate mismatch
bubbles at ZFN cut sites. CEL-II nuclease [26] cleavage of the
mismatch bubbles resulted in the predicted products (256 and
217 bp) for cleavage at the target site. Band densitometry of the
image in Figure 1B showed that the ratio of the summed cleavage
products to parental band was 66% (0.399/0.601) for the ZFN-
treated DNA supplied by the manufacturer (lane 2) and 68%
(0.403/0.597) for ZFN-transfected HCT116 cells (lane 4) in this
experiment, indicating a high frequency of site-specific mutations.
In later experiments, electroporation was used instead of lipid-
based transfection to further increase transfection efficiencies.
Clones isolated from ADPGK ZFN-treated populations were
screened by immunoblotting for the absence of the characteristic
54-kDa ADPGK band. Two candidate knockouts (HCT116 C3
and IC10) with no detectable ADPGK protein (Figure 1C) were
identified from two different rounds of transfection (C3 from
screening of 12 clones after FACS enrichment, and IC10 from 131
clones after electroporation without flow sorting using conditions
which gave transfection efficiencies of ,70% using a GFP
plasmid), indicating a low overall frequency of bi-allelic knockout
leading to complete loss of immunodetectable protein. A higher
proportion of clones appeared to show reduced ADPGK protein
expression (data not shown), possibly due to mutational inactiva-
tion of a single allele. To test whether the low frequency of null
lines (2/143 clones) reflects compromised survival or proliferation
in bi-allelic knockouts, we followed the frequency of mutations in a
ZFN-transfected HCT116 pool using the Surveyor (PCR/CEL-II
nuclease) assay. The 256 and 217 bp bands diminished over two
weeks in culture (Figure S1A), although a similar decrease over
time was seen with a separate ZFN pair targeting the 8th exon of
POR (Figure S1B), which encodes NADPH;cytochrome P450
oxidoreductase. POR-null HCT116 clones were isolated at higher
frequency (3/14) using the POR ZFN pair. Thus the progressive
loss of ADPGK and POR mutations is more likely to reflect
compromised proliferation/survival of cells with the highest
plasmid copy number after transfection.
Copy number within the ADPGK gene was assessed for the two
ADPGK null clones (C3 and IC10) by qPCR using primer pairs
flanking the ZFN target sequence (CNV2 and 3) and another
recognising exon 7 (CNV1) .31 kb away (Figure 1D). This
showed the presence of two copies of ADPGK in the knockouts, as
for the parent line (consistent with the Sanger Cancer Genome
Project; www.sanger.ac.uk/cgi-bin/genetics/CGP/cghviewer/
CghViewer.cgi), except for a single copy region near the ZFN
target cite in HCT116 clone C3. Sequencing across the ZFN
target site of genomic DNA from these null clones demonstrated
frameshift mutations in both (Figure 1E). These frameshifts
generate premature stop codons resulting in predicted truncated
proteins of 75 and 84 amino acids, lacking the ADP kinase domain
located between amino acids 52 and 497 of the full length isoform
(www.uniprot.org), and are thus expected to be catalytically
inactive. The finding of only one mutated (and no WT) sequence
Zinc Finger Nuclease Knockouts of ADP-Glucokinase
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for clone 1C10, coupled with a copy number of two at CNV2 and
3, suggests homologous recombination using the initial ZFN-
induced mutation as template resulted in reduction to homozy-
gosity. HCT116 C3 also provided only a single sequence at the
ZFN target site, but the copy number of one at CNV2 and 3
suggested a large deletion. This was confirmed by amplifying and
sequencing an extended region, identifying a 2963 deletion
spanning the CNV2 and CNV3 sites (Figure S2).
Transfection of H460 cells with the same ADPGK ZFN plasmids
yielded no ADPGK-null clones from screening of 127 clones after
nucleofection alone and screening of 24 clones after nucleofection
and FACS enrichment. This low efficiency may reflect the
presence of three ADPGK alleles in H460 (Sanger Cancer Genome
Project), which we confirmed with the qPCR-based copy number
assay (Figure S3). Two clones showed reduced ADPGK protein
levels (ID5 and VD6; Figure 2A), suggesting they may carry
mutant alleles, were therefore subjected to a second round of ZFN
transfection (electroporation and FACS), providing 5/121 clones
with no detectable ADPGK protein from which two were chosen
for further analysis (IID10 from ID5 and IIE5 from VD6)
(Figure 2A). Copy number determination (Figure 2B) in conjunc-
tion with sequencing of the ZFN target site (Figure 2C) showed a
homozygous frameshifting compound deletion/base substitution
mutation for clone H460 IIE5 giving a predicted truncated protein
of 89 amino acids. Clone IID10 had a 62-bp deletion in at least
one allele, potentially generating a protein of 62 amino acids, while
Figure 1. APDGK knockout in HCT116 cells using zinc-finger nucleases. (A) Features of the ADPGK gene, with location of primer pairs and the
dimeric ZFN targeting site. (B) PCR/CEL-II nuclease (Surveyor) assay for mutation detection at the ZFN target site. HCT116 cells were transfected with a
pair of ADPGK ZFNs and a GFP plasmid. One day later genomic DNA was prepared from pooled FACS sorted GFP positive cells for the assay (Lane 4).
Lane 1: DNA ladder. Lane 2: positive control DNA from ADPGK ZFN-treated K562 cells. Lane 3: Untreated HCT116 cells. (C) ADPGK ZFN-treated HCT116
cells cloned and screened for ADPGK by western blot. (D) Genomic DNA copy number by qPCR for primer pairs CNV1-3. Results are plotted relative to
WT DNA which has two ADPGK alleles. (E) Sequencing across ZFN recognition site (predicted cut site in lower case) resulted in deletions (2) and
insertions (underlined) for ADPGK-null HCT116 clones C3 and IC10. The inferred copy number for each allele is shown.
doi:10.1371/journal.pone.0065267.g001
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the other allele(s) carry a number of duplications of a segment of
DNA downstream from the ZFN cutting site, which were not fully
identified.
Proliferation and Clonogenicity of ADPGK Knockout Cell
Lines
The ADPGK-null cell lines from both genetic backgrounds
showed similar doubling times to the WT lines when cultured
under standard aerobic cell culture conditions (Figure 3A and B),
with a possible slight reduction in cell proliferation for the
HCT116 IC10 line. Colony morphology by phase contrast
microscopy was also similar to the parental cell lines (Figure 3C
and D) although the H460 IID10 cells were somewhat more prone
to rounding up and detaching from the dish.
To further investigate proliferation, HCT116 and H460 cell
lines were cultured under normoxia for 54 and 72 h,
respectively, and cell number, cell volume, cell cycle distribution
and clonogenicity was measured (Table 1). No significant
differences were observed for HCT116 C3 compared to WT;
however a two-fold increase in G1 phase cells was seen for
HCT116 IC10, consistent with the reduction in proliferation
noted above. Plating efficiency was similar for all three
HCT116 cell lines, but the slower proliferation of HCT116
IC10 was reflected in a significantly decreased colony radius.
Both H460 ADPGK-null clones showed a small but significant
decrease in cell number, and a small increase in G2/M phase
cells. Additionally, H460 IID10 had an increased mean cell
volume and showed a trend towards decreased plating efficiency
as well as decreased colony radius, possibly due to the
detachment of cells from the colonies. Overall, the results
suggest a minor effect on proliferation but this was not a
consistent finding across cell lines and clones.
Global Gene Expression in ADPGK-null Lines
To investigate whether knockout of ADPGK affects gene
expression, two ADPGK –null clones (HCT116 C3 and H460
IIE5) with similar proliferation and colony morphology to their
parental lines were chosen for microarray analysis using Affyme-
trix Human Gene 1.0 ST microarrays. Single cultures of the
HCT116 C3 ADPGK-null line and HCT116 parental cells were
compared in a first experiment, and duplicate cultures of both the
HCT116 and H460 pairs in a second experiment.
The transcriptome of the ADPGK –null HCT116 C3 line
appeared to be broadly similar to that of the WT HCT116 line
(Figure 4A) and no differentially expressed transcripts were
identified when the false discovery rate was controlled to 5% by
the Benjamini-Hochberg method. While this analysis suggested
that the number of apparently differentially expressed transcripts
was no greater than expected due to chance, it remains possible
that small numbers of mRNA transcripts may be authentically
regulated following ADPGK gene inactivation in HCT116 cells.
There was no evidence for changes in expression of glycolytic
genes other than an apparent 2-fold decrease of glucose
transporter SLC2A3. Intriguingly though, within the top-ranked
22 probe sets (Table S1), transcripts from eight Y-chromosome
genes were down-regulated in the knockout line. On comparing
Figure 2. APDGK knockout in H460 cells using zinc-finger nucleases. (A) Western blots of H460 cells after transfection with ADPGK ZFNs
(clones ID5 and VD6), and ADPGK-null clones derived from these in a second round of ZFN transfection (IID10 and IIE5). (B) Genomic DNA copy
number by qPCR for primer pairs CNV1-3. Results are plotted relative to WT DNA which has three ADPGK alleles. (C) Sequencing across the ZFN cut
site shows deletions (2) and insertions (underlined) for the ADPGK alleles in H460 clones IID10 and IIE5.
doi:10.1371/journal.pone.0065267.g002
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the karyotype of HCT116 C3 with the WT line, we noted that the
latter contains a subpopulation of cells retaining a Y chromosome
while the HCT116 C3 line (and the HCT116 1C10 line)
comprises only a single karyotype lacking the Y chromosome
(Table S2). Thus the down-regulation of Y-chromosome tran-
scripts may be an artifact resulting from clonal selection of a Y-
minus variant.
Knockout of ADPGK in H460 (clone IIE5) caused a visibly
greater alteration in gene expression (Figure 4B). Most notably the
probe set for cadherin 11 (CDH11) was significantly decreased, by
150-fold, in H460 IIE5 (p= 0.03). No other differentially expressed
transcripts were identified when the false discovery rate was
controlled to 5% by the Benjamini-Hochberg method, a
conservative statistical threshold that is appropriate when so few
replicates are available. Nevertheless, plotting the expression
differences of the top-ranked 50 probe sets in a heatmap shows a
visible but not statistically significant distinction between WT
H460 line and the IIE5 H460 knockout clone duplicate cultures
(Figure 4C). While there was no evidence for changes in the
abundance of glycolytic mRNAs, two mRNAs encoding regulators
of cellular metabolism did appear to be differentially expressed just
below the level of statistical significance (PPARGC1A, 3-fold
downregulated; and AKT3, 2.7-fold upregulated). Cadherins 2, 6
and 10 were also differentially expressed .2.5-fold but below the
level of significance. The top-ranked 150 probe sets from H460
(Table S3) were chosen for further analysis with the gene ontology
tool DAVID ([27]; http://david.abcc.ncifcrf.gov/tools.jsp). Close
to 50% of the input genes were associated with the plasma
membrane and predicted to be glycosylated, 20% were localised to
the extracellular space and ,16% were associated with cell
adhesion (Table S4). Analysis using the GeneSetDB pathway
analysis tool [28] also revealed that the top-ranked 150 probe sets
Figure 3. ADPGK knockout clones of HCT116 (A, C) and H460 (B, D) show growth and morphology similar to the respective WT lines
in vitro. (A/B). Cell density after seeding 24-well plates at 105/ml. Values are mean and SEM for triplicate cultures. (C/D). Phase contrast microscopy
(106 objective magnification) of WT and knockout clones in T flasks.
doi:10.1371/journal.pone.0065267.g003
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from H460 cells were significantly enriched (p#0.05) for Gene
Ontology (GO, http://www.geneontology.org/) categories of
‘Adherens junction organisation’ and ‘Cell junction assembly’,
and for the Reactome (http://www.reactome.org/) molecular
Table 1. Proliferation and clonogenicity of HCT116 and H460 cell lines under normoxia.
Sample
Fold increase in
cell number
Mean cell volume
(fl) Cell cycle Clonogenic assay
G1/G0 S G2/M Plating efficiency (%) Colony radius (mm)
HCT116 (54 h incubation)
HCT116 WT 3.3260.17 1722617.8 30.160.7 46.760.4 22.060.4 113.065.7 0.9160.004
C3 3.1860.26 172260.3 26.160.8 48.360.5 24.660.5 115.764.5 0.9260.002
IC10 3.0060.38 167669.3 58.761.0 * 25.660.6 * 14.560.3 * 96.666.3 0.6460.016 *
H460 (72 h incubation)
H460 WT 12.8760.10 1814643.0 60.360.8 29.561.0 8.860.3 92.062.3 0.5460.007
IIE5 9.3860.29 * 1824636.0 59.460.1 28.660.1 10.360.3 * 92.165.9 0.5460.004
IID10 9.4460.83 * 2338638.8 * 61.060.9 28.060.8 10.060.2 * 75.9614.7 0.4360.007 *
Asterisks indicate significant (p,0.05) difference from WT by one-way ANOVA/Holm-Sidak. Proliferation parameters of respective cell lines are displayed as mean6 SEM
for three biological replicates.
doi:10.1371/journal.pone.0065267.t001
Figure 4. Global gene expression in ADPGK-null HCT116 (clone C3) and H460 (clone IIE5) cell lines. RNA was analyzed using Affymetrix
Human Gene 1.0 ST microarrays (A) Scatterplot showing mean expression values for HCT116 C3 versus WT (3 cultures each). (B) Scatterplot showing
mean expression values for H460 IIE5 versus WT (2 cultures each). (C) Heat map of the 50 top-ranked differentially expressed probe sets in duplicate
cultures of H460 WT and H460 IIE3. (D) qPCR of RNA from 3 replicate cell cultures each for H460 WT and ADPGK knockout clones IIE5 and IID10,
normalised against 18S rRNA.
doi:10.1371/journal.pone.0065267.g004
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pathway categories of ‘Adherens junctions interactions’ and ‘Cell
junction organisation’.
In order to confirm suppression of mRNA for cadherin 11 and
other cell adhesion molecules that appeared to be differentially
expressed following ADPGK knockout (NCAM2, L1CAM and
CDH2), their expression was quantified by qPCR in H460 WT
and both the ADPGK-null clones IIE5 and IID10 (Figure 4D).
ADPGK mRNA was also quantified by qPCR, and demonstrated
low transcript abundance in the mutant clones consistent with
nonsense-mediated decay. Expression of CDH11 was strongly
suppressed in the ADPGK knockouts (.10,000-fold in H460 IIE5
and ,200-fold in H460 IID10). NCAM2 and L1CAM RNA were
decreased in the range of 30 to 40-fold and 3 to 4-fold,
respectively, in both the ADPGK-null clones. CDH2 was only
decreased in H460 IIE5 (,1000-fold). In contrast, this suppression
of CDH11, NCAM2 and LICAM was not detected when ADPGK was
knocked down to , 80% of WT levels by siRNA (Figure S4)
suggesting that complete loss of gene function may be required for
this phenotype.
Effect of ADPGK Knockout on Cell Survival and Glycolysis
in HK2-depleted Cells and Under Anoxia and Hypoxia
The above studies indicated little if any effect of ADPGK
knockout on cell proliferation or plating efficiency (clonogenicity)
under normal growth conditions. We therefore tested whether
ADPGK might contribute to cell survival when glucose phos-
phorylation is restricted by treatment with HK2 siRNA, or when
glycolytic demand is increased under strictly anaerobic conditions
(6-h anoxia). One day after transfection of H460 WT, IIE5 and
IID10 with HK2 siRNA or GC-matched control siRNA, HK2
knockdown as measured by qPCR was in the range 70–80%
(Figure 5A). Two days after transfection with control siRNA, cell
numbers of knockout clones were not significantly different from
WT, although a small trend towards reduced proliferation was
noted for H460 IID10 as above (Figure 5B). HK2 siRNA
significantly reduced cell numbers in WT cultures relative to
control siRNA, and both knockout clones showed a small but
significant further decrease in cell number compared to HK2
siRNA treated WT (Figure 5B). Plating efficiency of the cells
treated with control siRNA, scored 10 days after re-plating cells,
was also reduced for the IID10 line (,50% of that for H460 WT),
but not for IIE5 (Figure 5C).
The ability of glycolytic restriction (HK2 siRNA) or increased
glycolytic demand (anoxia) to further suppress clonogenicity was
evaluated by calculating the surviving fraction (plating efficiency as
a fraction of that for the normoxic control siRNA-treated cells).
HK2 siRNA killed 79% of H460 WT (surviving fraction 0.21 in
Figure 5D) and the resulting colonies were smaller (40% reduction
in mean colony radius; data not shown). Notably, both HK2
siRNA transfected ADPGK-null cell lines showed an additional
highly significant ,4-fold loss of clonogenicity (Figure 5D), with
no further change in colony size, compared to WT also treated
with HK2 siRNA. When cells were re-plated in an anaerobic
chamber and exposed to 6 h anoxia before being transferred to an
aerobic CO2 incubator, clonogenic survival of WT cells decreased
by 71% (Figure 5E) and colony radius by 30% (not shown). Both
H460 ADPGK-null cell lines were significantly more sensitive to
killing under anoxia (Figure 5E), with no further change in colony
radius. HK2 knockdown in combination with anoxia had a similar
effect on viability to that seen under aerobic conditions, again with
a significantly greater effect in the ADPGK-null than WT lines
(Figure 5F).
Increased sensitivity of both ADPGK knockout H460 clones to
anoxia was confirmed in a second set of experiments, both with
and without the glycolytic inhibitor 2-deoxy-D-glucose (Figure S5).
These experiments clearly show that ADPGK has a protective effect
against cell death under anoxia and when HK2 is knocked down
under aerobic or anoxic conditions in the H460 cell line.
A similar study to that for H460 cell lines was conducted for
HCT116 WT and its ADPGK-null derivatives C3 and IC10 (Figure
S6). In this case, the only statistically significant effect of ADPGK
knockout was a modest decrease in plating efficiency (of the
control siRNA-treated cells) which appeared to be more
pronounced than in the experiment without control RNA
transfection reported in Table 1. Knockdown of HK2, and
exposure to anoxia for 6 h, caused less cell killing of HCT116
WT than H460 WT cells by a factor of ,2, and knockout of
ADPGK did not further increase killing by HK2 siRNA or anoxia in
the HCT116 background.
We further investigated whether prolonged exposure of hypoxia
(0.2% oxygen in gas phase) has a similar effect on H460 ADPGK-
null clones as shown for anoxia. All three cell lines proliferated at
similar rates under hypoxia for 3 or 6 d, with no significant
difference in the fold increase in clonogens per culture (Figure
S7A). Similarly, ADPGK knockout had no consistent effect on
growth of HCT116 clonogens under 0.2% oxygen for 3, 6, or 9
days (Figure S7B).
The apparent difference in effects of ADPGK knockout on
survival of H460 cells under anoxia versus 0.2% oxygen led us to
test activation of the unfolded protein response (UPR), which is
more pronounced under severe than moderate hypoxia [29,30].
XBP1 splicing by the IRE-1 endonuclease, a marker of UPR [31],
showed similar increases in H460 ADPGK-null clones and WT cells
after 6-h anoxia (Figure S8).
Effects of ADPGK Knockout on Glycolysis and
Mitochondrial Metabolism
We next tested whether the effects of ADPGK knockout on H460
survival under anoxia reflect a role of ADPGK in glycolysis.
Glucose consumption and lactate formation during 6-h anoxia
were suppressed when HK2 was knocked down in H460
(Figure 6A, B) and HCT116 (Figure 6C, D) cell lines, establishing
that glucose phosphorylation is rate-limiting for glycolysis under
these conditions. Surprisingly, there was no evidence for a lower
glycolytic rate in the ADPGK knockouts, and glycolysis in the
knockouts was no more sensitive to HK2 suppression. Similarly,
knockdown of HK2 suppressed steady-state ATP levels (under
either aerobic or anaerobic conditions) in H460 cell lines, but this
effect was no greater for any of the ADPGK-null clones (Figure 7A).
Anoxia and HK2 siRNA had only minor effects on ATP levels in
HCT116 WT cells, consistent with the lesser effect of these
treatments on clonogenic survival than in H460 cells, with no
obvious differences in the ADPGK knockout clones (Figure 7B).
To further investigate the potential role of ADPGK in
glycolysis, we also evaluated rates of aerobic glycolysis using a
Seahorse XF24 Extracellular Flux Analyser. WT and ADPGK-null
cells of both genetic backgrounds were assayed in unbuffered
DMEM media, and extracellular acidification rates (ECAR) and
oxygen consumption rates (OCR) were measured simultaneously.
Knockout of ADPGK had no effect on ECAR, a proxy measure of
glycolytic flux [32], in H460 when assayed in media containing
5 mM glucose, 1 mM pyruvate and 1 mM glutamate (Figure 8A)
or media containing 5 mM glucose exclusively (Figure 8B).
However, when glucose was decreased to 1 mM both ADPGK-
null cell lines showed a small but statistically significant (p = 0.002)
reduction in ECAR compared to H460 WT (Figure 8C). In
HCT116 cells, knockout of ADPGK had no effect on ECAR
(Figure 8D-F), with the exception of clone HCT116 C3, which
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surprisingly showed an increase in ECAR in media containing
pyruvate and glutamate additionally to glucose (Figure 8D).
However, removal of pyruvate and glutamate from the media
reduced ECAR in clone HCT116 C3 below that of HCT116WT
cells (Figure 8E) and could suggest more complex interactions
between multiple metabolic pathways in this particular clone.
Interestingly, knockout of ADPGK in both HCT116 and H460
cells resulted in clone- and glucose-dependent reductions in OCR.
In H460 cells, the IID10 clone showed the most pronounced
reductions in OCR, at all glucose concentrations, as did the IC10
clone in HCT116 cells. Residual oxygen consumption in the
presence of the ATP synthase inhibitor oligomycin and complex
III inhibitor antimycin A (i.e. non-mitochondrial oxygen con-
sumption) was in most cases unchanged for the knockout lines
relative to the parental cells (Figure S9).
To investigate whether these reductions in basal OCR were
dependent on glycolytic flux, we examined OCR in media
containing 5 mM glucose, 1 mM pyruvate and 1 mM glutamate,
following the addition of 2-deoxy-D-glucose to block glycolytic
flux. After the addition of 2-deoxy-D-glucose, ECAR decreased by
,50%, while OCR was not altered, in all cell lines (Figure S10).
These data suggest that impaired glucose oxidation does not
account for the oxidative phenotype observed. The 3-fold
reduction in expression of peroxisome proliferator-activated
receptor gamma coactivator 1-alpha (PPARGC1A), a key regulator
of mitochondrial biogenesis, in H460 clone IIE5 by microarray
(Table S2) suggested a possible mechanism for the reduced OCR.
Suppression of PPARGC1A in IIE5, and in the second H460
ADPGK-null clone IID10 was confirmed by qPCR which showed a
20-fold reduction in both clones compared to WT, although
siRNA knockdown of ADPGK (which lowered ADPGK mRNA to
31611% of control values in this experiment) did not suppress
PPARGC1A (Figure 9). To further investigate potential conse-
quences of reduced PPARGC1A expression, we measured mito-
chondrial mass, using Mitotracker staining (Figure S11A), and
found no differences between any of the cell lines. Furthermore,
we found no differences in electron transport chain complex
protein expression in HCT116 cells (Figure S11B). However, in
H460 cells, protein expression of components of the electron
transport chain complexes I and II appeared to be reduced in the
IID10 clone and was associated with a loss in mitochondrial
membrane potential (Figure S11C). These data suggest that
ADPGK can induce clonal dependent alterations in mitochondrial
metabolism.
ADPGK Knockout Tumours: Growth and Hypoxic Fraction
of Xenografts
To investigate whether ADPGK influences xenograft growth
and/or hypoxic fraction in tumours, xenografts were grown from
two ADPGK knockouts, HCT116 C3 and H460 IIE5, and their
WT counterparts. No difference in growth as subcutaneous
tumours was found for the ADPGK knockout clones (Figure 10A/
B). Western blots from fresh frozen samples of each tumour that
reached the endpoint size showed a reduction of the 54-kDa
ADPGK band in most of the ADPGK knockout tumours, but a
residual band of varying intensity was evident (Figure 10C). This
presumably reflects a variable murine stromal component, given
that the antibody also recognised murine ADPGK in mouse liver
samples; this is consistent with the presence of a cross-reactive
25 kDa band in mouse liver and in the ADPGK knockout tumour
samples with the most intense 54 kDa bands (Figure 10C).
Figure 5. Knockout of ADPGK in H460 lowers clonogenic survival under anoxia and when HK2 is knocked down. HK2 was knocked
down by siRNA in two independent experiments, combined here, each of which included three biological replicates for WT and two for each
knockout clone. (A) HK2 mRNA by qPCR one day after siRNA transfection. (B). Cell number two days after siRNA transfection, at which time cells were
replated for clonogenic assay. (C) Plating efficiencies of two days after transfection with control siRNA. (D) Effect of HK2 siRNA on clonogenic surviving
fraction two days after transfection, relative to cells transfected with control siRNA. (E) Effect of 6 h anoxia on clonogenic surviving fraction, relative to
oxic controls, determined by plating cells in an anoxic chamber two days after siRNA transfection and transferring to an aerobic incubator 6 h later.
(F) Effect of HK2 siRNA on clonogenic surviving fraction after exposure to 6 h anoxia, relative to an equivalent anoxic exposure after control siRNA.
doi:10.1371/journal.pone.0065267.g005
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H&E staining and immunohistochemistry for the hypoxic probe
pimonidazole did not reveal any differences in necrotic or hypoxic
tumour area for any of the groups or cell lines (Figure 10D and E).
The analysis was not biased by the tumour size, since there was no
significant difference in tumour weights between groups (data not
shown). In a second small study with HCT116 WT and C3
xenografts, no obvious difference was seen in staining for
pimonidazole, the proliferation marker bromodeoxyuridine or
the TUNEL apoptosis assay (Figure S12).
Discussion
In this study we use a pair of ZFNs, custom-designed to target a
genomically unique sequence in the ADPGK gene (Figure 1A), to
generate human tumour cell lines with frameshift mutations at the
target site and which completely lack ADPGK protein by
immunoblotting. The truncated proteins predicted from sequenc-
ing the region near the ZFN target site represent 62–89 amino
acid N-terminal fragments which would not be detected by the
antibody we used, which recognises a C-terminal epitope [13].
However, these truncated proteins would almost entirely lack the
ADP kinase catalytic domain (amino acids 52–497) and particu-
larly the likely active site aspartate at position 481 and metal ion
binding residues at 297 and 328 (www.uniprot.org), and are thus
expected to be catalytically inactive. In addition the low
abundance of the mutant ADPGK transcripts (Figure 4D),
consistent with nonsense-mediated decay, indicates that any such
N-terminal fragments are likely to be poorly expressed.
It is of note that two of the four ADPGK-null clones we isolated
harboured homozygous mutations, including identical mutations
in all three alleles in H460 IIE5. It is presumed that reduction to
homozygosity occurred in these cases through ongoing ZFN-
induced cutting of the wild type allele, resulting in homology-
directed repair with the mutant allele as template, as has been
suggested previously [33,34]. The frequency with which multi-
allelic knockout was achieved was , 1.5%, with 2/143 screened
HCT116 clones lacking ADPGK expression. This contrasts to the
much higher proportion of mutations at the ZFN target site as
demonstrated by the Surveyor mutation detection assay
(Figure 1B), which detects monoallelic mutations as heteroduplex-
es (predominantly with the WT sequence). This suggests that
reduction to homozygosity is a relatively infrequent event in the
Figure 6. Knockdown of HK2 suppresses anaerobic glycolysis in H460 and HCT116, but knockout of ADPGK has no effect. Glucose
consumption (A, D) and lactate formation (B, E) were measured 2 days after transfection with control siRNA or HK2 siRNA. Cells were re-seeded in
fresh medium at 26105 per ml in 96-well plates in an anaerobic chamber, and the culture medium was assayed 6 h later. Values are mean and SEM
for 3 independent experiments. Asterisks indicate a significant difference for HK2 siRNA relative to control siRNA (p,0.05).
doi:10.1371/journal.pone.0065267.g006
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HCT116 cell line, leading to a low recovery of ADPGK-null
clones. We have not been able to rigorously exclude the possibility
that ADPGK-null clones are selected against because the genotype
compromises cell proliferation or survival. The loss of mutations
from ZFN-transfected pools over time (Figure S1A) would be
consistent with this interpretation, except that most of the
mutations in these pools are almost certainly monoallelic; the lack
of effect of ADPGK knockdown by RNAi on viability and
proliferation of HCT116 cells [13] indicates that haploinsuffi-
ciency does not result in a lethal phenotype. The observation of a
similar progressive loss of POR mutations when HCT116 cells are
transfected with a POR ZFN pair (Figure S1B), despite apparently
more efficient recovery of null mutants (3/14 clones), suggests that
the declining mutant frequency reflects compromised proliferation
of the cells with highest plasmid copy number, possibly reflecting
toxicity of highly expressed ZFNs [35–37]. Nonetheless, the low
yield of ADPGK-null clones leaves open the possibility that
secondary mutations or epigenetic changes could have rescued the
rare ADPGK knockouts we isolated.
The efficiency of generation of ADPGK-null clones seemed to
be even lower in H460, which required two rounds of ZFN
transfection with 0/151 null lines in the first round and 5/121 on
re-transfection of candidate partial knockouts; this lower efficiency
may in part reflect the presence of three ADPGK alleles in this line.
As yet there is little information to provide comparison with the
efficiency of multi-allelic gene disruption by ZNF in other
mammalian cell lines. Much higher rates have been reported for
genes that are X-linked [38] or otherwise functionally haploid
[39], or when the knockout provides a selectable phenotype
[40,41], but rates vary widely at other loci [33,39,40,42]. The
difficulties in distinguishing between low efficiency of multi-allelic
knockout and rescue by compensating genetic/epigenetic changes
with ZFN technology is likely to be particularly problematic with
tumour cells given the dual problems of genomic instability and
high gene copy number at many loci.
Clonal heterogeneity in tumour cell lines also represents a
challenge for use of ZFN in that knockout clones and parental lines
are unlikely to be strictly isogenic, and phenotypic differences may
thus not have a causal relationship to the targeted mutations.
Heterogeneity in the HCT116 line was evident in the karyotypic
analysis; the parental line comprised subpopulations with and
without a Y-chromosome as well as a polyploid variant, which is
consistent with the karyotype reported by ATCC, while the
ADPGK knockout clones were derived from the Y-minus
pseudodiploid variant (Table S2) and lacked Y-chromosome
transcripts (Table S1). Ideally a larger number of clones would
have been evaluated in the present study, but this was precluded
by the very low efficiency with which multi-allelic knockouts were
recovered. Clonal heterogeneity is likely to be an important
confounding factor in ZFN gene editing studies with tumour cell
lines, and suggests that it would be advantageous to use cell lines
that are relatively competent for homology-directed repair which
would be expected to minimise genotypic diversity in the parental
line as well as maximising gene conversion at the target locus
(potentially leading to higher efficiency recovery of homozygous
mutations).
Despite the low efficiency in production of null clones using
ZFN, knockout of ADPGK in H460 resulted in a marked
phenotype in relation to clonogenic survival under anoxia or
when glycolysis is restricted with siRNA against HK2 (Figure 5D-
F). This phenotype was consistent in both H460 clones, but
appears to be cell line dependent given that no such effects were
observed in the two HCT116 knockout clones. This difference
might reflect the higher ADPGK protein levels in H460 than
HCT116 [13], or differences in ADPGK activity as a result of
post-translational modification. The mechanism of transient
activation of ADPGK during T-cell receptor signalling is
unknown, but it occurs in the absence of a change in protein
levels and is dependent on PKC-h [18] suggesting a possible role
for phosphorylation. Bioinformatic analysis using NETPHOS 2.0
[43] with a threshold of 0.5 suggests that 18 serine and 3 threonine
residues of full-length human ADPGK are potential phosphory-
lation sites, but this has yet to be investigated experimentally. In
relation to the cell line dependence of ADPGK knockout, it is
perhaps also relevant that HCT116 cells were more resistant to
these glycolytic stresses as indicated by a lesser effect of HK2
suppression and anoxia on cell survival (Figure S6) than for H460.
In our previous siRNA study [13], knocking down ADPGK by 70–
90% in H460 cells did not increase sensitivity to clonogenic cell
killing under anoxia. Thus ZFN-mediated knockout may provide a
clearer phenotype than RNAi, as also suggested in the present
study by the strong reduction in PPARGC1A expression on
Figure 7. Steady state ATP levels are more sensitive to HK2
suppression in H460 than HCT116 cells, but knockout of ADPGK
has no effect in either. ATP was measured 2 days after transfection
with control siRNA or HK2 siRNA, following re-seeding in fresh medium
for 6 h under normoxia (ox) or anoxia (anox). Values are mean and SEM
for 3 biological replicates. Asterisks indicate significance (p,0.05) of
HK2 siRNA treated vs. siRNA control treated cells. Hash indicates p,0.05
for difference between anoxic vs. normoxic conditions.
doi:10.1371/journal.pone.0065267.g007
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knockout of ADPGK but not when it was knocked down with
siRNA (Figure 9).
Given the clear effect of knocking out ADPGK on clonogenic
survival of H460 under these stress conditions (Figure 5), we were
surprised to find no observable effect on glycolysis in either H460
clone (or in the HCT116 knockouts). These studies used two
independent measures of glycolysis (glucose consumption/lactate
production in bulk cultures, and extracellular acidification rate in
unbuffered media with a Seahorse analyser), and failed to reveal
any defect in glycolysis even under conditions of HK2 knockdown
and anoxia (Figure 6). In addition, knockout of ADPGK also did
not further compromise steady-state ATP levels in cells in which
glycolysis was inhibited with HK2 siRNA (Figure 7). Thus the
effect of ADPGK on survival of H460 cells under these stress
conditions appears not to be mediated by a direct effect on
glycolytic flux. The studies with the Seahorse analyser also
evaluated mitochondrial oxygen consumption in aerobic cultures,
and interestingly, demonstrated a reduction in most ADPGK
knockout clones in most media (Figure 8). This decrease in
respiration on knockout of ADPGK is the reverse of the reported
suppression of respiration in T-cells when ADPGK activity is
stimulated through T-cell receptor/diacylglycerol signaling [18].
In addition, there was no consistent evidence for changes in
oxygen consumption in the presence of oligomycin and antimycin
A in the knockouts (Figure S9), as might be expected if ADPGK
increases generation of ROS as in activated T-cells [18]. Thus
Figure 8. Reduced oxygen consumption rate (OCR) but not extracellular acidification rate (ECAR) in ADPGK knockout cells under
aerobic conditions. Basal OCR and ECAR were measured in H460 (A–C) and HCT116 (D–E) ADPGK knockout cell lines and their respective wild types
(WT) using a Seahorse XF analyser with monolayers in different media as indicated. Values are mean and SEM from two independent experiments
with five biological replicates each.
doi:10.1371/journal.pone.0065267.g008
Figure 9. Effect of knockout of ADPGK, and its knockdown by
siRNA, on expression of PPARGC1A in H460 cells. PPARGC1A
expression was measured by qPCR in WT and the two ADPGK-null
clones, and in H460 WT cells two days after treatment with control or
ADPGK siRNA. Standard errors are shown for 3 replicate cultures with 3
technical replicates each.
doi:10.1371/journal.pone.0065267.g009
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ADPGK does not appear to participate in an analogous signalling
pathway in HCT116 or H460 tumour cells under the conditions
we have tested. The marked decrease in expression of PPARGC1A
in the H460 knockouts (Figure 9) suggested that compromised
mitochondrial biogenesis might be responsible for the decrease in
oxygen consumption. In support of this hypothesis, we did observe
a decrease in electron transport chain complex I and II expression,
which could limit the reduction of the electron transport chain and
ultimately reduce oxygen consumption. Consistent with this
finding, we also observed a decrease in mitochondrial membrane
potential in the IID10 H460 clone. It is unclear whether this is due
to a direct effect of ADPGK on mitochondrial biogenesis
processes, or due to feedback to these same processes from altered
metabolic flux. However, in an effort to explain the difference
between our findings and those observed with oxygen consump-
tion in activated T-cells, it is possible that these effects could also
be context-dependent and determined by specific signaling to
ADPGK, as we have suggested for the wider functions of ADPGK.
Furthermore, variability between clones leaves open the question
as to whether changes in oxygen consumption represent a real
effect of ADPGK or a manifestation of clonal heterogeneity.
Given the important role of hypoxia as a driver of tumour
angiogenesis [44], we sought to determine whether the reduced
survival of H460 ADPGK knockouts under anoxia in vitro translates
Figure 10. Tumour xenograft growth from ADPGK WT and knockout cell lines. Kaplan-Meier plots showing time for HCT116 (A) and H460
(B) tumours to reach endpoint. 5-6 mice/group. (C) Immunoblots of lysates from fresh frozen tumours and mouse liver at the tumour growth
endpoint. (D) Proportion of tumour area which is necrotic, as determined by H&E staining of histological sections at endpoint (4 tumours/group). (E)
Proportion of tumour sections positive for the hypoxia probe pimonidazole, by immunostaining, in the same tumours as for D.
doi:10.1371/journal.pone.0065267.g010
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into compromised growth as tumour xenografts. ADPGK knockout
had no discernible effect on growth of the H460 or HCT116
clones, and steady state hypoxic fractions were unaffected in the
resulting tumours (Figure 10). This apparent difference between
in vitro and in vivo phenotypes let us to evaluate effects of moderate
hypoxia (0.2% O2 gas phase) as distinct from anoxia in vitro; even
for the H460 line showing greater sensitivity to anoxia, prolifer-
ation of clonogens under hypoxia was not compromised by
knockout of ADPGK (Figure S7). Thus moderate levels of hypoxia
in tumours, sufficient to induce HIF-1 stabilisation and angiogen-
esis, do not appear to result in ADPGK dependence. Our results
suggest that ADPGK may not be a useful target for cancer therapy,
although it needs to be born in mind that the current investigation
explores just two clones from each of two human tumour cell lines.
The intriguing observation of a clear effect of ADPGK on survival
of H460 cells under certain stress conditions in vitro indicates that a
deeper understanding of its role in tumour cell biology is needed.
In particular, the effect on survival but not apparently glycolysis
(despite the demonstrated ability of purified ADPGK to catalyse
ADP-dependent glucose-6-phosphate formation [12,13]) raises the
question whether this ancient gene might have been co-opted for
other functions during metazoan evolution, perhaps analogous to
the roles of mitochondrially-bound HK2 in suppressing apoptosis
and ROS generation [45,46] and of PK-M2 as a co-activator of
HIF-1 [47]. The recent demonstration of the diversion of
glycolytic flux by ADPGK to hyper-reduce ubiquinone and drive
mitochondrial generation of ROS, in response to T-cell receptor
signaling, also raises the possibility that ADPGK might contribute
to elevated ROS production in some tumour cells. However, we
observed no consistent difference in oxygen consumption in the
cells lines examined in the present study following antimycin
exposure, which in part reflects mitochondrial ROS generation,
nor consistent alterations in mitochondrial membrane potential.
This suggests that modulation of ADPGK levels in H460 and
HCT116 cells did not affect the reduced state of the respiratory
chain or ROS production. The gene expression changes observed
in H460 cells suggest that ADPGK might also regulate expression
of cell adhesion molecules in some contexts, indicating a possible
avenue for further investigation. In addition, Adpgk knockout
mouse embryonic stem cells are now available, providing another
important opportunity for evaluation the role of this enigmatic
gene in mammalian biology.
Materials and Methods
Ethics Statement
Animal experiments were conducted under protocols approved
by the University of Auckland Animal Ethics Committee (approval
number CR830).
Cell Culture and Generation of ADPGK-null Lines using
Zinc-finger Nucleases
H460 and HCT116 cell lines were obtained from the American
Type Culture Collection (ATCC), VA and used within 90 days
passage from frozen stocks confirmed to be mycoplasma negative
using a PCR-Elisa kit (Roche, Switzerland). All cell lines were
grown in alphaMEM (Invitrogen, CA), supplemented with 5%
foetal bovine serum (FBS). Cells were subjected to anoxia (0%
oxygen in a 5% CO2/5% H2/90% N2 gas phase) in a Bactron Pd
calatyst anaerobic chamber (Sheldon Manufacturing, OR), using
plasticware and solutions equilibrated to anoxia for at least three
days before the experiment.
Plasmids for expression of a pair of custom-designed Com-
poZrTM Fok1 ZFNs against two 18 base pair target sites in the first
exon of the human ADPGK gene (chromosome 15:73,043,636-
73,076,126) were purchased from Sigma Aldrich, MO. The
targeted region is: 59-CCGGGACCCGTCTCCCCC-
gagggCCGGTTGGCGGCAGCCTGG-39, where the lower case
bases indicate the untargeted Fok1 nuclease site. A second ZFN
pair, also purchased from Sigma Aldrich, targets the sequence
CATAGATGCGGCCAAGGTgtacatGGGGGAGATGGGCCG
in the 8th exon of the POR gene. Plasmids were transfected into
cells using LipofectamineTM LTX and Plus reagent (Invitrogen,
CA) according to the manufacturer’s instructions (for generation of
HCT116 C3), or alternatively by nucleofection (Lonza, Switzer-
land) using NucleofectorTM solution V and programs D-032 for
HCT116 and T-030 for H460. Co-transfection with a GFP-coding
plasmid (pEGFP-N1, Clontech) and subsequent fluorescence-
activated cell sorting (Becton Dickinson FACSVantage Cell
Sorter) was used in some cases to enrich for positively transfected
cells (for generation of clones HCT116 C3, H460 ID10 and IIE5).
ZFN-transfected cells were cloned by limiting dilution in 96 well
plates, and after growing for 7 days wells containing a single
colony were trypsinised and expanded in duplicate wells, one of
which was trypsinised and extracted (Laemmli buffer, Bio-Rad
Laboratories, CA) for screening by western immunoblotting.
Clones H460 IID10 and HCT116 IC10 were found to be
contaminated with mycoplasma; all data presented below (except
Figures 3, 5, 6 and S6) was obtained after elimination with
PlasmocureTM (Invivogen, CA).
Surveyor Mutation Detection Assay
Genomic DNA was extracted according to the manufacturer’s
instructions using the GenEluteTM Mammalian Genomic DNA
Miniprep Kit (Sigma-Aldrich, MO). 100 ng of DNA, primers 59-
GTAGCGCTTGTGTCGACATCGGCGC-39 and 59-CA-
GACGTCCGACACTTCTCGCCAAG-39 and Extract-N-
AmpTM Blood PCR Ready MixTM (Sigma-Aldrich, MO) were
combined to amplify the ADPGK ZFN cutting site. The primers for
the POR ZFN site were 59-CAAAAGGGCTCATTTCCT-
TAAAATC-39 and 59-GCTAAGTGAGCTCAGTA-
CAAACTGG-39. The Surveyor mutation detection assay, using
the CEL-II nuclease, was performed as per the manufacturer’s
instructions (Transgenomic Inc., NE). Products were resolved on a
2% agarose gel and band densitometry was undertaken using
Image J software.
Sequencing of the ZFN Cutting Site
Genomic DNA from WT cells and knockout clones was
amplified by PCR using primers surrounding the ZFN cut site
(ADPGK_P1): 59-GGGGACAAGTTTGTACAAAAAAG-
CAGGCACCGTAGCGCTTGTGTCGACATCGGCGC-39
and 59-GGGGACCACTTTGTACAAGAAAGCTGGGTTC-
CAGACGTCCGACACTTCTCGCCAAG-39, which include
attB sites for Gateway cloning (underlined). The products were
cloned into pDONR221 via GatewayTM cloning (Invitrogen, CA)
and the plasmid was transformed into E. coli. Eight colonies for
each cell line were picked for plasmid extraction and DNA
sequencing. To uncover large deletions, a second primer set
(ADPGK_P2) further away from the ZFN cut site was employed:
59-ACAGCAGGTCCCATAGCAAC-39 and 59-CCCAC-
CAATTCATATGCTGA-39.
Western Immunoblotting
SDS-PAGE and western blotting was performed as previously
[13]. Primary antibodies were mouse monoclonals against
ADPGK and HK2 (Abnova, Taiwan), rabbit polyclonal anti-
GAPDH (Abcam, UK) and mouse monoclonal anti-actin
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(Chemicon International). Secondary HRP-coupled anti-mouse
and anti-rabbit antibodies were from Santa Cruz Biotechnology,
CA.
Karyotyping and qPCR Copy Number Variation (CNV)
Assay
Log-phase cultures were treated with colcemid (50 ng/ml, 1 h)
and metaphases were prepared for Trypsin-Giemsa staining using
standard methods [48,49]; 20 metaphases were analysed for each
cell line. qPCR was performed using the Platinum SYBR Green
qPCR SuperMix-UDG with ROX module (Invitrogen, CA) and
10 ng of genomic DNA as template. Reactions were performed in
quadruplicate in a total volume of 10 ml using the ABI 7900HT
Fast Real-Time PCR System (Applied Biosystems, CA) with the
following program: 50uC 2 min, 95uC 10 min, 40 cycles of 95uC
15 s, 60uC 30 s, 72uC 30 s. Primer sets were designed to assess
copy number at three different sites, within exon 7 of ADPGK gene,
immediately down and upstream of the ZFN cut site (see
Figure 1A): CNV1 (59-CTCACCCAACATCCTGGTCT-39, 59-
TTTGTCCTTAGCGGCTCTGT-39); CNV2 (59-
TTGCTAATCCCGCTTTGTCT-39, 59-ACGCGTCTTCAA-
GAAGTTCAG-39); CNV3 (59-AGGCCTGGAAGAGGA-
CAAGT-39, 59-ATCCCCAAATAGAGGGATGG-39). All values
were normalized relative to the house keeping gene RPP21:59-
AGGTTCTGGGTTGGTGTGAG-39, 59-
TGTGTTTGGCAAGGGTTGTA-39. For analysis, the software
package SDS 2.3 and RQ manager from Applied Biosciences, CA
was used. Copy numbers were calculated by using the formula
2?22DDCt (Ct = cycle threshold). HCT116 with two ADPGK copies
(www.sanger.ac.uk/cgi-bin/genetics/CGP/cghviewer/
CghViewer.cgi) was employed as calibrator.
Proliferation, Cell Volume, Cell Cycle Distribution and
Clonogenicity
Cell number and cell volumes were determined from trypsinized
monolayer cultures (combined with the original medium to include
any floating cells) using a Beckman Coulter counter (Z2 Coulter
Particle Count and Size Analyzer). Cell cycle distributions were
determined after fixation in 70% ethanol and staining with
propidium iodide (10 mg/ml in 0.1% Triton X-100, 100 mg/ml
DNase-free RNase A in PBS) for 30 min using an LSR II flow
cytometer (BD) and analyzed with FACSDIVA software (BD). 100
or 1000 cells were seeded in triplicate for clonogenic assay as
previously [13].
mRNA Microarrays
Cell lines were seeded at 2.56104 cells in T25 flasks. After four
days, culture medium was removed and 750 ml TRIZOLH RNA
extraction reagent (Invitrogen, CA) was added. RNA was
extracted using Qiagen RNeasy Mini columns following the
manufacturer’s instructions. The quality of the total RNA (1 mL)
was checked using the Eukaryotic Total RNA 6000 Nano Assay
on an Agilent 2100 Bioanalyser according to the manufacturer’s
protocol (Agilent, CA). Subsequently, total RNA was processed
using the Affymetrix Whole Transcript (WT) Sense Target
Labeling Assay Rev. 5, and fragmented, labelled single-stranded
DNA was hybridised to Affymetrix GeneChipH Human Gene 1.0
ST arrays at 45uC in a hybridisation oven for 17 h. The arrays
were washed and stained using the Affymetrix protocol FS450
_0001 in an Affymetrix GeneChip Fluidics Station 450, and
scanned in an Affymetrix GeneChip Scanner 7G. Data analysis
was undertaken using R version 2.11.0 with the following
Bioconductor packages and libraries: affy, limma, gdata, gplots
and hugene11stprobeset.db. Specifically, raw microarray data at
the probe level was normalised using the Robust Multiarray
Analysis method with background correction (RMA [50], provid-
ed by the R ‘affy’ package). For quality control, Expression
Console software (Affymetrix, CA) and R were used. The raw and
normalized array data, and the relevant MIAME compliant
metadata, can be accessed from GEO with accession number
GSE39497 (www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc =GSE39497).
Quantitative Real-time PCR (qPCR)
qPCR was performed as detailed in [13] with additional primer
pairs for CDH11 [51]; CDH2 [52]; NCAM2 [53]; L1CAM [54] and
PPARGC1A [55].
Measurement of Glycolysis, ATP and Oxygen
Consumption
HK2 siRNA treatment, glucose and lactate measurements and
ATP assays were performed as previously [13]. Extracellular
acidification rate (ECAR) and oxygen consumption rate (OCR)
were measured with a Seahorse XF analyser (Seahorse Bioscience,
MA) in unbuffered DMEM (no serum, Sigma-Aldrich, MO)
containing either 5 mM glucose, 1 mM glucose or 5 mM glucose/
1 mM pyruvate/1 mM GlutamaxTM (Invitrogen, CA) as sub-
strates. Plates were incubated for 60 min in a non-CO2 incubator
at 37uC before three basal measurements were undertaken
determining oxygen and proton concentration in the medium.
Then the glycolytic inhibitor 2-deoxy-D-glucose (100 mM) was
injected, or (in separate studies) the ATP synthase inhibitor
oligomycin (1 mM) and the complex III inhibitor antimycin A
(1 mM) were injected serially, with three further measurements
after each addition. Seahorse plates had all media removed,
without disrupting the cell monolayer, and were frozen at 280uC,
immediately after the conclusion of the assay. Cell number in each
well was determined using the CyQUANT kit (Invitrogen, CA),
according to manufacturer’s instructions. All OCR and ECAR
values were normalized to 56104 cells.
Tumour Xenografts
Immunodeficient female NIH-III nude mice (NIH-Lystbg-
Foxn1nuBtkxid), approximately 21 g body weight, were housed in
groups of 4–6 under specific pathogen-free, controlled ambient
conditions (2262uC, 12 h day/night lighting cycle) with standard
rodent diet (Harlan Teklad diet 2018i) and sterile water supplied
ad libitum. Tumour cells (76106/site) were inoculated subcutane-
ously on the right flank. Tumours were measured every 2–3 days
using digital calipers and volumes were calculated as width26
length6p/6. Tumours were harvested at approximately 1 cm3,
90 min after dosing the mice intraperitoneally with 1000 mg/kg
bromodeoxyuridine (Sigma-Aldrich, MO) and/or 60 mg/kg
pimonidazole (HPI Inc.). Mice were culled by cervical dislocation
and tumours were excised immediately. Half of each tumour was
frozen in liquid nitrogen, stored at 280uC and subsequently
pulverized using a liquid N2-cooled Biopulveriser (BioSpec
Products, OK) and lysed using Laemmli buffer. The other half
was fixed with 10% neutral buffered formalin for 36–48 h, then
70% histology alcohol (18:1:1 ethanol/methanol/isopropyl alco-
hol) before paraffin embedding and cutting 5 mm sections.
Immunohistochemistry
FFPE sections were deparaffinised and antigen retrieval was
carried out using 10 mM sodium citrate buffer pH 6.0 in a
pressure cooker for 25 min, followed by cooling on ice for 10 min.
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Non-specific binding was blocked by incubation with 10% goat
serum in TBS (0.2 M Tris, 1.37 M NaCl pH 7.6) for 1 h in a
humidified chamber. FITC-pimonidazole monoclonal antibody
(HypoxyprobeTM, HPI Inc.) was diluted 1:25 in 5% goat serum in
TBS and incubated overnight at 4uC in a dark humidified
chamber. The next day, coverslips were mounted with ProLongH
gold antifade reagent (Invitrogen, CA). Slides were stored at 4uC
in the dark until imaging with a Nikon TE2000E Inverted
microscope (montage function). The same tumour section were
then stained with hematoxylin & eosin (H&E, Sigma-Aldrich,
MO) and re-imaged. The percentage of necrotic and hypoxic
regions in tumour sections was calculated using ImageJ.
Statistics
Descriptive statistics report the mean and SEM for biological
replicates (separate cultures) unless otherwise indicated. Signifi-
cance of difference between two groups was tested using Student’s
t-test, and significance between more than two groups was
evaluated by one-way ANOVA/Holm Sidak.
Supporting Information
Figure S1 Changes in mutation frequency in HCT116 pools
during growth after transfection with ZFNs. HCT116 cells were
co-transfected with a GFP plasmid and with plasmid pairs for
ADPGK ZFNs (A) and POR ZFNs (B) by nucleofection, and 24 h
later 25% of the cells with the brightest GFP fluorescence were
sorted. Genomic DNA was prepared on the indicated day after
transfection (day 1 sample obtained immediately after sorting), and
the mutation frequency was assessed using the Surveyor mutation
detection assay. For ADPGK the positive control is a reference
DNA sample from ADPGK ZFN-treated K562 cells, provided by
Sigma Aldrich, showing the predicted Surveyor products (256 and
217 bp, arrows). For POR the positive control is from a POR null
clone (Hko3) with two mutant alleles (a M263L missense mutation
and a one-bp insertion) at the ZFN target site that gives predicted
Surveyor products of 417 bp and 248 bp (arrows).
(TIF)
Figure S2 Characterisation of the large ADPGK deletion in
HCT116 clone C3. Yellow marks the binding site for primer pair
ADPGK_P2. Grey marks the WT sequence deleted in HCT116
C3. The ADPGK start codon ATG is underlined and the ZFN
recognition site is marked in red (with cutting site in lower case).
(TIF)
Figure S3 ADPGK copy number of HCT116, H460 and SiHa.
Copy number was determined via qPCR with HCT116 as
calibrator with known copy number of 2 (according to Sanger
Institute, cancer genome project). Primers amplify a 175 bp
sequence located within exon 7 of the ADPGK gene. Error bars
show the SEM for four technical replicates. Boxed numbers
indicate copy number identified by the Sanger Institute (www.
sanger.ac.uk/cgi-bin/genetics/CGP/cghviewer/CghViewer.cgi).
All cell lines were obtained from the American Type Culture
Collection (ATCC), VA.
(TIF)
Figure S4 No decreased expression of cell adhesion molecules
when ADPGK is knocked down in H460. RNA from three separate
experiments was isolated one day after transfection (RNAi-
MAXTM, Invitrogen, CA) with both control siRNA and ADPGK
siRNA (Invitrogen, CA). RNA was transcribed into cDNA and
analysed by qPCR. All values are normalised against 18S rRNA,
and error bars represent the standard error of three biological
replicates each.
(TIF)
Figure S5 ADPGK KO reduces anoxic cell survival but not
lactate formation in H460, and 2-deoxy-D-glucose (2DG) has no
effect on these parameters. H460 cells (WT, KO clone IIE5 and
IID10) were plated in an anoxic chamber for 2 h before being
treated with 2 concentrations of 2DG (1 mM, 10 mM, Sigma-
Aldrich, MO) or saline only for 4 h. Graphs show results from 3
independent experiments with 3 experimental replicates each. A.
Anoxic surviving fraction measured by clonogenic assay after
exposure to 6 h anoxia. B. Lactate formation measured in culture
medium after 4 h exposure to saline or 2DG.
(TIF)
Figure S6 Knockout of ADPGK in HCT116 does not affect
clonogenic survival under anoxia and when HK2 is knocked down.
HK2 was knocked down by siRNA in two independent
experiments, combined here, each of which included three
biological replicates for WT and two for each KO clone. (A)
HK2 mRNA by qPCR one day after siRNA transfection. (B). Cell
number two days after siRNA transfection, at which time cells
were replated for clonogenic assay. (C) Plating efficiencies of two
days after transfection with control siRNA. (D) Effect of HK2
siRNA on clonogenic surviving fraction two days after transfec-
tion, relative to cells transfected with control siRNA. (E) Effect of
6 h anoxia on clonogenic surviving fraction, relative to oxic
controls, determined by plating cells in an anoxic chamber two
days after siRNA transfection and transferring to an aerobic
incubator 6 h later. (F) Effect of HK2 siRNA on clonogenic
surviving fraction after exposure to 6 h anoxia, relative to an
equivalent anoxic exposure after control siRNA.
(TIF)
Figure S7 Knockout of ADPGK in H460 (A) and HCT116 (B)
does not affect cell growth or clonogenic survival under chronic
hypoxia. Cells were seeded at 20,000, 1000 or 200 cells/well into
24-well plates and exposed to 3, 6 or 9 days of hypoxia (0.2%
oxygen in gas phase), respectively. Cell number was measured
using a Beckman Coulter counter and cells were re-plated for 10
days to measure clonogenic survival. Asterisks indicate significance
(p,0.05) compared to WT. For HCT116 cell lines, two separate
experiments were performed. Hypoxia (0.2% oxygen 5% CO2/
N2) was achieved with an anaerobic glove box system and an
oxygen controller (Coy Laboratory Products, Inc.). For long-term
exposure, plates were partially enclosed in plastic bags containing
trays of water to maximise humidity.
(TIF)
Figure S8 XBP1 splicing under anoxia in H460 cell lines. RNA
from H460 WT and two ADPGK-null clones was extracted after
exposure to either 6-h normoxia (1 culture each) or anoxia (3
cultures each). RNA was transcribed into cDNA and analysed by
qPCR. Two primer pairs, one reporting on total XBP1
(GGCATCCTGGCTTGCCTCCA; GCCCCCTCAG-
CAGGTGTTCC) and one reporting on spliced XBP1
(CGCTTGGGGATGGATGCCCTG;
CCTGCACCTGCTGCGGACT) were used. All values were
normalised against 18S rRNA, and the ratio between spliced and
total XBP1 was calculated. Error bars represent standard error.
(TIF)
Figure S9 Inhibition of oxygen consumption by oligomycin and
antimycin. Oxygen consumption rate (OCR) in ADPGK-null
clones and parental (WT) cell lines in the indicated culture media,
determined using a Seahorse XF Analyser, and normalised to
50,000 cells. Values are mean and errors are SEM for five
biological replicates, and are derived from two timepoints for basal
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conditions and three measurements after addition of oligomycin
(1 mM) and antimycin A (1 mM). Asterisks indicate significance
(p,0.05) of differences from the respective WT.
(TIF)
Figure S10 Inhibition of glycolysis by 2-deoxy-D-glucose (2DG).
Five replicate cultures of each cell line were seeded in complete
medium (5 mM glucose, 1 mM pyruvate, 1 mM glutamate), and
EACR and OCR were measured with a Seahorse XF Analyser.
After addition of 100 mM 2DG (Sigma-Aldrich) measurements
were repeated. Asterisks indicate significance (p,0.05) of differ-
ences from the respective WT.
(TIF)
Figure S11 Knockout of ADPGK in H460 and HCT116 has no
effect on mitochondrial mass (A), but has clone-dependent effects
on electron transport chain subunit expression (B) and mitochon-
drial membrane potential (C). For (A), cells were seeded at 25,000
cells per well in black, clear bottom 96 well plates. 24 hours later,
cells were stained with 50 nM Mitotracker Green FM (Life
Technologies) for 30 min. Media was replaced and the plate was
scanned with a florescent plate reader at excitation 490 nm and
emission 515 nm. For (B), protein lysates were separated using
SDS-PAGE before immunoblotting with the Mitoprofile Total
OXPHOS Antibody Cocktail (Mitosciences). For (C), cells were
seeded as for (A), but were stained with 2 mg/mL JC-1 (Life
Technologies) for 20 min before the plate was scanned with a
florescent plate reader at excitation 490 nm and emission at
522 nm and 605 nm. Data was expressed as a ratio of aggregated
JC-1 (605 nm) to monomeric JC-1 (522 nm) as an indication of
mitochondrial membrane potential. * denotes statistically different
from WT (p,0.01).
(TIF)
Figure S12 HCT116 xenografts from WT and ADPGK
knockouts. A. Lysates from each tumour were used to confirm
the ADPGK expression status by western blot (one sample per lane).
D. Three different sections from each tumour were stained for
either hypoxic areas using pimonidazole (PIMO, green), prolifer-
ating areas using bromodeoxyuridine (BrdUrd, brown) or
apoptotic areas using the TUNEL assay (red). One example for
each group is displayed. PIMO and BrdUrd images are taken in
106 objective magnification. The TUNEL image was taken at
406 objective magnification and represents the region marked
with the black box. For bromodeoxyuridine staining, peroxidase
block (DAKO Dual Endogenous Enzyme Block) was performed
for 10 min at RT before antigen retrieval. Blocking was carried
out using rodent block M (Biocare, CA) for 30 min at RT in a
humidified chamber, Horseradish peroxidise conjugated rat anti-
bromodeoxyuridine antibody (Serotec, UK) was diluted 1:25 in
HRP-STABILPLUSTM (Serotec, UK) and incubated for 1 h at
RT in a humidified chamber. Substrate-chromogen DAB
(EnVisionTM Detection Systems Peroxidase/DAB, DAKO, Den-
mark) was applied for 8–10 min before being rinsed off. TUNEL
assay was performed using the ApoptagH Red In Situ Apoptosis
Detection kit (Chemicon International Inc.).
(TIF)
Table S1 HCT116 microarray: top 50 probe sets in order of p
values.
(DOCX)
Table S2 Karyotypes of HCT116 WT cells and ADPGK
knockout clones.
(DOCX)
Table S3 H460 microarray: top 150 probe sets in order of p
values.
(DOCX)
Table S4 Gene ontology (GO) analysis of potential differentially
expressed genes in ADPGK knockout clone H460 IIE5 using
DAVID.
(DOCX)
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